title: The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation.
authors.affiliation: Department of Radiation Oncology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, 48109-5637, USA.
authors.forename: Hongren
authors.initials: H
authors.lastname: Yao
authors.forename: Donna M
authors.initials: DM
authors.lastname: Veine
authors.forename: Kevin S
authors.initials: KS
authors.lastname: Fay
authors.forename: Evan D
authors.initials: ED
authors.lastname: Staszewski
authors.forename: Zhao-Zhu
authors.initials: ZZ
authors.lastname: Zeng
authors.forename: Donna L
authors.initials: DL
authors.lastname: Livant
mesh_terms: D020533:Angiogenesis Inhibitors / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D045744:Cell Line, Tumor; D002465:Cell Movement; D050091:Dendrimers / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D020128:Inhibitory Concentration 50; D039081:Integrin alpha5beta1 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy / Q000473:pathology; D020781:Matrix Metalloproteinase 1 / Q000378:metabolism; D051379:Mice; D008819:Mice, Nude; D009361:Neoplasm Invasiveness / Q000517:prevention & control; D009842:Oligopeptides / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D050091:Dendrimers; D039081:Integrin alpha5beta1; D009842:Oligopeptides; D020781:Matrix Metalloproteinase 1